NEW YORK (GenomeWeb News) - Caliper Life Sciences said today that it has signed an agreement to sell its Pharmaceutical Development & Quality Analysis, or PDQ, product line to pharmaceutical testing firm Sotax in a deal worth around $15.8 million.
 
The sale of Caliper’s PDQ product line, which includes products for drug content uniformity and dissolution rate testing and related services, is expected to close next month.
 

Get the full story

This story is free
for registered users

Registering provides access to this and other free content.

Register now.

Already have an account?
Login Now.

Mary Beckerle has been removed as director of the Huntsman Cancer Institute in what one researcher refers to as a "coup," ScienceInsider reports.

Bill Gates tells the Telegraph that bioterrorism is a serious risk.

The March for Science is to take place tomorrow, and supporters are tapping their creative energies to create placards to carry.

CBS News reports that the White House Science Fair is to continue under President Donald Trump.